| Long name: |
ALEXA FLUOR 350 Conjugated, NFATC4 (Ser168 + Ser170) Antibody |
| Also known as: |
Anti-NFATC4 Ser168 + Ser170 PAb ALEXA FLUOR 350 |
| Category: |
Conjugated Primary Antibodies |
| Conjugated with: |
350, ALEXA FLUOR® |
| Host Organism: |
Rabbit (Oryctolagus cuniculus) |
| Target Antigen: |
NFATC4 Ser168 + Ser170 |
| Specificity: |
This is a highly specific antibody against NFATC4 Ser168 + Ser170 |
| Modification: |
Phosphorylation |
| Modification Site: |
Ser168 + Ser170 |
| Clonality: |
Polyclonal |
| Clone: |
Polyclonal antibody |
| Concentration: |
1ug per 1ul |
| Source: |
KLH conjugated synthetic phosphopeptide derived from human NFATC4 around the phosphorylation site of Ser168 + Ser170 |
| Gene ID Number: |
4776 |
| Tested applications: |
IF(IHC-P) |
| Recommended dilutions: |
IF(IHC-P)(1:50-200) |
| Crossreactivity: |
Mouse, Human |
| Cross-reactive species details: |
not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the antigen: |
Alternatively spliced transcript variants encodingdifferent isoforms have been noted for this gene, Oct 2008], Theproduct of this gene plays a role in the inducible expression ofcytokine genes in T cells, [provided byRefSeq, especially in the induction of the IL-2and IL-4, Other members of this family of nuclear factors of activated Tcells also participate in the formation of this complex, The product of this gene is a member of the nuclearfactors of activated T cells DNA-binding transcription complex, This complex consists of at least two components: a preexistingcytosolic component that translocates to the nucleus upon T cellreceptor (TCR) stimulation and an inducible nuclear component |
| Purification: |
Purified by Protein A |
| Storage conditions: |
50% glycerol and 0, Keep refrigerated at 2 to 8 degrees Celcius for up to one year, 09% sodium azide, Store this antibody in aqueous buffered solution containing 1% BSA |
| Excitation emission: |
343nm/442nm |
| Synonyms: |
NFAT3 |
| Properties: |
ALEXA FLUOR they should be stored frozen at - 24°, Alexa Fluor 350 conjugates can be used in multi-color flow cytometry with FACS's equipped with a second red laser or red diode, If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies, C, C for long term storage and for short term at + 5°, For facs or microscopy Alexa 1 conjugate |
| Conjugation: |
ALEXA FLUOR 350, Alexa Fluor |
| Gene target: |
NFATC4 (Ser168 + Ser170) |
| Short name: |
NFATC4 (Ser168 + Ser170) Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Label: |
ALEXA FLUOR 350 |
| Alternative name: |
ALEXA FLUOR 350, calcineurin-dependent 4 (Ser168 and Ser170) (Antibody to), cytoplasmic, nuclear factor on activated T-cells |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
DNA-templated and biological process this GO :0006366 and transcription from RNA polymerase II promoter and biological process this GO :0006954 and inflammatory response and biological process this GO :0007507 and heart development and biological process this GO :0008134 and transcription factor binding and molecular function this GO :0008630 and intrinsic apoptotic signaling pathway in response to DNA damage and biological process this GO :0032760 and positive regulation of tumor necrosis factor production and biological process this GO :0034644 and cellular response to UV and biological process this GO :0042975 and peroxisome proliferator activated receptor binding and molecular function this GO :0043065 and positive regulation of apoptotic process and biological process this GO :0045087 and innate immune response and biological process this GO :0045111 and intermediate filament cytoskeleton and cellular component this GO :0045333 and cellular respiration and biological process this GO :0045944 and positive regulation of transcription from RNA polymerase II promoter and biological process this GO :0048167 and regulation of synaptic plasticity and biological process this GO :0051145 and smooth muscle cell differentiation and biological process this GO :0055001 and muscle cell development and biological process this GO :0071285 and cellular response to lithium ion and biological process this GO :2001235 and positive regulation of apoptotic signaling pathway and biological process, NF-AT3 and NF-ATC4 and NFAT3, NFATC4 and IDBG-3927 and ENSG00000100968 and 4776, NFATC4 and IDBG-645671 and ENSBTAG00000006366 and, Nfatc4 and IDBG-166063 and ENSMUSG00000023411 and 73181, calcineurin-dependent 4, cytoplasmic, nuclei, peroxisome proliferator activated receptor binding, this GO :0000122 and negative regulation of transcription from RNA polymerase II promoter and biological process this GO :0000978 and RNA polymerase II core promoter proximal region sequence-specific DNA binding and molecular function this GO :0000981 and sequence-specific DNA binding RNA polymerase II transcription factor activity and molecular function this GO :0001078 and RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription and molecular function this GO :0001569 and patterning of blood vessels and biological process this GO :0003677 and DNA binding and molecular function this GO :0003700 and sequence-specific DNA binding transcription factor activity and molecular function this GO :0003713 and transcription coactivator activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005634 and nucleus and cellular component this GO :0005667 and transcription factor complex and cellular component this GO :0005737 and cytoplasm and cellular component this GO :0005829 and cytosol and cellular component this GO :0006355 and regulation of transcription, this GO :0000978 : RNA polymerase II core promoter proximal region sequence-specific DNA binding, this GO :0000978 : RNA polymerase II core promoter proximal region sequence-specific DNA binding and also this GO :0000981 : sequence-specific DNA binding RNA polymerase II transcription factor activity and also this GO :0001078 : RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription and also this GO :0003677 : DNA binding and also this GO :0003700 : sequence-specific DNA binding transcription factor activity and also this GO :0003713 : transcription coactivator activity and also this GO :0005515 : protein binding and also this GO :0008134 : transcription factor binding and also this GO :0042975 : peroxisome proliferator activated receptor binding, this GO :0000981 : sequence-specific DNA binding RNA polymerase II transcription factor activity, this GO :0001078 : RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription, this GO :0003677 : DNA binding, this GO :0003700 : sequence-specific DNA binding transcription factor activity, this GO :0003713 : transcription coactivator activity, this GO :0005515 : protein binding, this GO :0008134 : transcription factor binding, this GO :0042975 : peroxisome proliferator activated receptor binding, nuclear factor of activated T-cells |
| Identity: |
7778 |
| Gene: |
NFATC4 |
More about : NFATC4 |
| Long gene name: |
nuclear factor of activated T-cells 4 |
| Synonyms gene name: |
calcineurin-dependent 4 , cytoplasmic, nuclear factor of activated T-cells |
| Locus: |
14q12 |
| Discovery year: |
1994-11-16 |
| GenBank acession: |
BC053855 |
| Entrez gene record: |
4776 |
| Pubmed identfication: |
7749981 |
| RefSeq identity: |
NM_004554 |
| Classification: |
Nuclear factors of activated T-cells |
| Havana BLAST/BLAT: |
OTTHUMG00000029351 |